Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
71st Annual Meeting of the American College of Rheumatology
Therapeutic Approaches to Pain and Disability Associated with Fibromyalgia
Boston, Massachusetts / November 6-11, 2007
Boston - Fibromyalgia is a complex and challenging disorder that does not yield readily to conventional therapeutic approaches for the treatment of rheumatic diseases, experts here agreed. It has substantial impacts on both the physical...
23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis
Persistent Early Treatment Benefits in Longer-term Multiple Sclerosis Therapy
Prague, Czech Republic / October 11-14, 2007
Prague - The need to start multiple sclerosis (MS) therapy early in the course of the disease is no longer in doubt. Investigators here at the ECTRIMS meeting asserted that there is no time to lose, even in patients with clinically isolated...
23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Multiple Sclerosis: Examining New Trial Results
Prague, Czech Republic / October 11-14, 2007
Prague - This year’s ECTRIMS meeting featured findings from several long-awaited comparative studies on the two first-line immunomodulatory therapies for relapsing-remitting multiple sclerosis. The results suggest that while the short-term...
First World Congress on Controversies in Neurology
Consensus and Debate Regarding Treatment of Multiple Sclerosis
Berlin, Germany / September 6-9, 2007
Berlin - Data continue to emerge from landmark clinical trials supporting early intervention of patients living with multiple sclerosis (MS). This issue was one of two vigourously debated subjects at the inaugural World Congress on...
Third Congress of the International Society for Vascular and Cognitive Disorders
The Role of Cholinesterase Inhibitors in the Treatment of Mixed Dementia
San Antonio, Texas / July 11-14, 2007
San Antonio – Alzheimer’s disease (AD) frequently occurs in association with vascular disease in older individuals. The brain lesions associated with the two conditions interact in ways that increase the likelihood that a patient will have...
13th Congress of the International Headache Society
Inhibiting the Pathophysiology of Migraine: New Management Strategies
Stockholm, Sweden / June 28-July 1, 2007
Stockholm - Most cases of disabling headache seen by primary care physicians prove to be migraine, according to leading neurologists meeting here this week. A recent survey demonstrated that nearly 3.5 million Canadian adults suffer from...
17th Annual Meeting of the European Neurological Society
Evidence for Multiple Sclerosis Treatment Prior to Clinically Manifest Disease
Rhodes, Greece / June 16-20, 2007
Rhodes - Speakers here at the ENS meeting emphasized the importance of starting treatment for multiple sclerosis (MS) as soon as an MRI discloses disease activity. Leading neurologists focused on the implications in Betaseron in Newly...
8th Annual European Congress of Rheumatology (EULAR)
Confronting the Pain Paradigm of Fibromyalgia
Barcelona, Spain / June 13-16, 2007
According to Dr. Jordi Carbonell Abelló, Head, Rheumatology Unit, Hospitales del Mar y de la Esperanza, Barcelona, Spain, fibromyalgia is a common chronic pain condition with a great need for improved treatment options. He stressed...
49th Annual Scientific Meeting of the American Headache Society
Exploring Treatment Options for Refractory Migraine
Chicago, Illinois / June 7-10, 2007
Chicago - Migraine is the most common disabling headache challenging general practitioners and specialists alike today. The triptans have greatly advanced migraine management and as a class, they are effective in approximately two-thirds of...